Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of dyskinesia rating scales in Parkinson's disease
2009-016143-19Phase 4Completed
- Sponsor
- The Michael J. Fox Foundation for Parkinson's Research
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Parkinson's disease (PD) comparing Amantadine with Placebo (2 arms). Primary endpoints: AIMS change at 8 weeks, RDRS change at 8 weeks and 10 more. Started Feb 2010; status: completed.
02
Drugs
amantadine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2009-016143-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016143-19.